AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2025 Issue 4; ICD-10-PCS New/Revised Codes Section X—New Technology

Introduction of New Therapeutic Substances

In table XW0, Introduction of Anatomical Regions, 7 new substance values were added to identify the substances listed below. These substances have the qualifier value New Technology Group 11.Device/Substance/Technology F Valoctocogene Roxaparvovec-rvox P Aztreonam-avibactam Anti-infective Q Iloprost R Letetresgene Autoleucel T Rozanolixizumab-noli Monoclonal Antibody V Xanomeline and Trospium Chloride W Fosfomycin Anti-infective Valoctocogene Roxaparvovec-rvoxValoctocogene roxaparvovec-rvox is an intravenous infusion gene therapy vector that is used to treat adults with severe hemophilia A (congenital Factor VIII deficiency with Factor VIII activity <1 IU/dL) without antibodies to adeno-associated virus serotype 5. It is designed to introduce a functional copy...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .

Thank you for choosing Find-A-Code, please Sign In to remove ads.